Assessing human polychlorinated biphenyl contamination for epidemiologic studies: lessons from patterns of congener concentrations in Canadians in 1992. by Gladen, Beth C et al.
Polychlorinated biphenyls (PCBs) are industrial
compounds whose production began in 1929
(ATSDR 2000). Their largest use by volume
has been in electrical equipment such as capaci-
tors and transformers, but the list of other uses
is long and varied. Their extensive use and their
stability led to their release into and persistence
in the environment. The discovery of their
widespread presence in the environment,
together with information on their toxicity, led
to limitations on their manufacture in many
countries starting in the 1970s. However, the
stability of these compounds ensures that many
millions of kilograms remain in existence.
Persons throughout the world have been
exposed to these compounds, predominantly
through the presence of trace amounts in diet,
and measurable concentrations of some PCBs
can be found in virtually everyone to this day
(Schecter et al. 1994).
The toxicity of PCBs has been investi-
gated actively for many years, with interest
particularly spurred by accidental poisonings
in Japan in 1968 and Taiwan in 1979 (Hsu
et al. 1994; Masuda 1994). There was clear
toxicity seen in these unfortunate accidents,
but the nature and extent of toxicity of PCBs
at concentrations encountered in the general
human population are less clear and remain
under study (Longnecker et al. 1997).
PCBs are a group of 209 compounds; the
various members of the group are referred to
as congeners. Commercial production
involves mixing biphenyl with chlorine under
various reaction conditions, and the result is
always a complex mixture of congeners (plus
chemically related impurities). As an example,
an analysis of a typical sample of one product,
Aroclor 1254, detected 112 congeners, none
of which comprised more than 9.3% of the
mixture (Frame 2001).
Studying the toxicity of such a large
group of compounds is not simple. Although
there are properties shared by many con-
geners, there are also clearly differences. In
experiments, it is possible to administer single
congeners or suitably chosen combinations.
Such experiments have yielded insights and
suggestions of some general patterns (Hansen
1998). For example, congeners with the high-
est dioxin-like activity (through binding to
the aryl hydrocarbon receptor) tend to be
congeners with no chlorines in ortho posi-
tions. On the other hand, certain neurologic
effects tend to be more pronounced in ortho
congeners. However, the overall picture of
the toxicity of the 209 congeners remains
quite incomplete.
Humans are always exposed to mixtures
of congeners. Although the mixtures seen in
the environment differ from those in com-
mercial products because congeners differ in
their rate of degradation, individual PCBs are
not seen outside the laboratory. This compli-
cates the assessment of human contamina-
tion. Chemical assay methods for PCBs have
changed over the years (Erickson 1997). In
the past, results were reported as single sum-
mary measures of PCB concentration, either
as estimated Aroclor concentration or as total
PCBs. More recently, it has become practical
to assay individual congeners. Attention has
generally been limited, particularly in large
studies, to a relatively small number of con-
geners that are present in relatively high con-
centrations. Unfortunately, there is no
guarantee that the congeners that are impor-
tant for health are those that are present at
high concentrations. Potencies for dioxin-like
effects, for example, differ by orders of mag-
nitude (Van den Berg et al. 1998), and con-
geners with high dioxin-like potency are
generally present at quite low concentrations.
To help deal with this complexity, there
have been proposals to group congeners, or at
least congeners frequently detected in human
tissues, into biologically similar categories
(McFarland and Clarke 1989; Wolff et al.
1997). Another proposal developed lists of
congeners to be measured based on combina-
tions of concentrations seen in humans and in
the environment and information on known
toxicity (Jones 1988). These proposals,
although representing reasonable approaches
in principle, are based on incomplete informa-
tion about toxicity and do not incorporate
information on relative potency. For one
group of health outcomes mediated through
dioxin-like activity, an approach using sums of
concentrations weighted by their potencies to
bind to the aryl hydrocarbon receptor (called
toxic equivalents) has been developed (Van
den Berg et al. 1998); this is suitable for out-
comes resulting from this speciﬁc mechanism
of action but not for others acting through
different pathways (Burgin et al. 2001;
Kodavanti et al. 2001; Li and Hansen 1996a,
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remains elusive.
In addition, another feature of human
contamination needs to be considered.
Because humans are generally exposed to sim-
ilar mixtures, the patterns seen in different
individuals tend to have many similarities.
Previous investigations, many involving lim-
ited numbers of congeners or relatively small
populations, have shown that concentrations
of certain congeners in humans are positively
correlated, with some of the correlations
being quite high (DeVoto et al. 1997; Gladen
et al. 1999a; Glynn et al. 2000, 2001;
Longnecker et al. 2000; van den Berg et al.
1995). To the extent that high correlations
exist among congeners, there is both no need
to measure them separately and no ability to
distinguish their biologic effects. It is there-
fore of interest to determine the correlation
structure among larger numbers of congeners
in larger populations, to see whether these
kinds of ﬁndings hold more generally.
Here we have used previously assayed
results on 38 congeners from 497 human milk
samples taken from across Canada in 1992
(Newsome et al. 1995) to examine patterns of
correlation among congeners. We have also
examined correlations of PCBs with some
other common organochlorines; although
these have different origins, they may travel
through the same environmental pathways.
Materials and Methods
The data used here have been described pre-
viously (Newsome et al. 1995). Briefly,
human milk samples were obtained from 497
women 19–46 years old from five regions
across Canada in 1992; women agreed to
donate milk after receiving an introductory
letter about the study. Concentrations of 38
PCB congeners (or coeluting congener pairs)
and a number of other organochlorine com-
pounds were measured by gas chromatogra-
phy with election capture detection; spiked
and unspiked control samples were included
in each batch, and every tenth sample was
confirmed semiquantitatively by mass spec-
trometry. Table 1 shows the PCB congeners
measured, identifying them both by con-
gener number and chlorine structure. Note
that the congener identified as 201 in the
original publication is called 199 in current
nomenclature (Erickson 1997). PCBs and
the other organochlorines measured here are
lipophilic, and concentrations of milk lipids
vary substantially over the short term, dou-
bling over the course of a single feeding and
exhibiting diurnal variation (Jensen et al.
1992). In our samples, the median percent-
age lipid was 3.1, with a range from 0.1 to
13.5. To eliminate this extraneous variability,
we expressed concentrations as nanograms of
compound per gram of milk lipid.
For all congeners, some samples were
below the minimum quantitation limit. We
converted limits originally expressed as
nanograms per gram milk to nanograms per
gram lipid by using the lipid content for each
individual sample. Information on actual con-
centrations, where available, and on limits, for
those not quantiﬁed, can be combined using
censored data techniques. (Such techniques
are more commonly used when large values
are only partially known, e.g., when estimat-
ing survival times when some individuals are
still alive. The principles are identical with
small values that are only partially known.)
We used standard life-table techniques,
specifically the product-limit estimator, to
estimate the median and other percentiles of
the distributions (Kaplan and Meier 1958).
For estimation of correlations, we assumed
that all pairs of congeners had joint normal
distributions on the logarithmic scale, and
used maximum likelihood to estimate the cor-
relation while accounting for the censored
observations. As with estimation of per-
centiles, information on either actual concen-
trations or limits, whichever was available,
was used in the calculation. That is, the likeli-
hood contribution for each sample was either
the probability of seeing the observed value (if
the sample was quantiﬁed) or the probability
of being below the quantitation limit (if the
sample was not).
Results
The distribution of PCB congeners in these
samples has been described previously
(Newsome et al. 1995), but some descriptive
statistics are given here for convenience
(Table 1). Twelve of the congeners were quan-
tiﬁed in at least 90% of the samples. Another
12 were quantiﬁed in 40–90% of the samples.
The remaining 14 congeners were quanti-
fied in fewer than 30% of the samples. For
these congeners, available information was
quite limited. Among the samples that were
quantified, concentrations were usually near
the quantitation limit; most were less than
twice the limit. When converted to concen-
tration per lipid weight, the varying lipid con-
tent of the samples caused considerable
overlap between the quantiﬁed amounts and
the quantitation limits. Those not quantiﬁed
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Table 1. Distribution of PCB congeners in 497 milk samples from Canada in 1992.
Congener Chlorine Percent  Median 90th  percentile Maximum
number(s) structure quantiﬁed (ng/g lipid) (ng/g lipid) (ng/g lipid)
138 234-245 99.6 24.2 44.5 308
153 245-245 99.6 33.4 62.5 395
118 245-34 98.8 14.2 26.7 213
137 2345-24 98.8 10.0 23.0 736
170 2345-234 98.6 7.8 15.3 70
187 2356-245 98.2 7.2 14.4 51
49 24-25 98.0 9.5 24.0 294
156 2345-34 97.4 5.3 10.9 90
180 2345-245 97.4 17.9 35.9 132
74 245-4 97.2 12.1 21.6 130
203 23456-245 91.5 2.4 5.0 20
105 234-34 90.5 4.4 8.4 72
99 245-24 89.9 11.9 23.2 144
199 2345-2356 89.7 4.3 9.1 46
183 2346-245 88.3 3.6 6.5 75
194 2345-2345 85.9 3.1 6.6 102
28 24-4 84.5 4.1 8.6 96
66 24-34 72.6 3.0 5.7 24
60 234-4 53.1 1.8 8.8 318
157 234-345 51.7 1.4 3.2 28
44 23-25 50.7 2.1 11.2 258
193 2356-345 49.5 1.3 3.7 222
90/101                      235-24/245-25 46.9 1.7 4.1 17
128 234-234 43.1 0.9 5.3 22
206 23456-2345 29.8 — 2.2 14
141 2345-25 25.8 — 1.9 12
191 2346-345 25.8 — 1.5 26
129 2345-23 23.7 — 2.5 14
189 2345-345 22.5 — 1.3 23
185 23456-25 22.3 — 1.3 7
52 25-25 21.7 — 3.7 24
110 236-34 19.3 — 5.1 34
151 2356-25 17.9 — 2.5 28
41 234-2 16.9 — 1.3 11
37 34-4 15.5 — 5.9 85
33 34-2 13.9 — 1.9 10
40 23-23 13.9 — 1.1 59
209 23456-23456 13.9 — 1.9 42
Median not shown for those with low percentage quantiﬁed because they are unreliably estimated.could, on a lipid basis, actually be as high as
or higher than those quantiﬁed, if lipid con-
tent was low. For example, for congener 52,
there were 108 quantiﬁed and 389 not. Those
quantiﬁed had a median of 3.1 ng/g lipid; for
those not quantiﬁed, the median quantitation
limit was 3.2 ng/g lipid. Results for the other
congeners in this group were similar. These
14 congeners were not considered further.
Tables 2 and 3 show correlations among
the 24 congeners with at least 40% quanti-
fied. Many of the major congeners were
highly intercorrelated; this is the case whether
one deﬁnes major as meaning a high percent-
age quantified or as meaning a high median
concentration. Congeners 138, 153, 156,
157, 170, 183, 187, 194, 199, and 203
formed a particularly tight group; each con-
gener had at least one correlation of 0.90 or
higher with another congener in the group,
and all correlations among the group were at
least 0.67. The mono-ortho congeners 74,
105, and 118 had correlations at least 0.80
with each other; correlations with the first
group were at least 0.48 and generally much
higher. Congener 180 showed moderate to
high correlations with these two groups.
Congeners 99 and 66 showed more modest
correlations yet.
Except the correlations of congener 66
with 90/101 and 28, all other correlations
were below 0.5. Two striking exceptions to
the pattern of major congeners being highly
intercorrelated were congeners 49 and 137.
Congener 137 had only moderate correlations
with any other congener, and 49 had very low
correlations with virtually all other congeners.
We also looked at the correlations of
PCBs with other major organochlorine com-
pounds. Table 4 describes the distribution of
the 14 compounds that were quantiﬁed in at
least 40% of the samples. Correlations
among these 14 were not generally high
(Table 5); the two trichlorobenzenes were
fairly highly correlated, as were the trio of
trans-nonachlor, hexachlorobenzene, and oxy-
chlordane. Most of these compounds showed
low correlations with PCBs (Table 6); how-
ever, trans-nonachlor, p,p´-DDE (dichloro-
diphenyldichloroethylene) and o,p´-DDT
(dichlorodiphenyltrichloroethane) showed
fairly high correlations with the major corre-
lated PCB groups identiﬁed above.
Discussion
Most previous studies giving correlations
among congeners involved fewer samples,
fewer congeners, or both. However, the
results are generally consistent with those
found here. Some previous studies presented
actual correlations, as we did here. At least
ﬁve such studies with sample size greater than
100 exist, all with fewer congeners than were
studied here (Table 7). There are studies of 9
congeners in 490 women, 4 congeners in 418
women, 18 congeners in 197 women, 4 con-
geners in 141 patients, and 10 congeners in
120 men. A number of similar smaller studies
also exist; details are given in Table 7. Other
authors have instead presented groupings sug-
gested by principal components or factor
analysis; such analyses provide less detail than
the original correlation matrices, but the
results are generally similar to those in the
Articles | Lessons from patterns of PCBs in humans
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Table 2. Correlations among PCB congeners in 497 milk samples from Canada in 1992, for those with at
least 90% quantiﬁed.
Congener 153 138 118 137 170 187 49 180 156 74 203 105
153 1
138 0.99 1
118 0.83 0.86 1
137 0.40 0.42 0.37 1
170 0.94 0.91 0.73 0.43 1
187 0.88 0.85 0.70 0.41 0.90 1
49 0.27 0.28 0.27 0.29 0.22 0.25 1
180 0.81 0.77 0.65 0.37 0.83 0.81 0.30 1
156 0.95 0.95 0.80 0.41 0.92 0.83 0.24 0.78 1
74 0.86 0.87 0.85 0.32 0.77 0.70 0.17 0.64 0.83 1
203 0.80 0.75 0.60 0.40 0.87 0.89 0.16 0.76 0.78 0.62 1
105 0.77 0.80 0.87 0.32 0.69 0.66 0.21 0.53 0.74 0.80 0.61 1
99 0.70 0.73 0.69 0.28 0.57 0.54 0.04 0.47 0.63 0.71 0.50 0.67
199 0.73 0.69 0.54 0.39 0.83 0.90 0.18 0.75 0.73 0.56 0.96 0.55
183 0.90 0.89 0.74 0.43 0.89 0.91 0.19 0.74 0.84 0.74 0.89 0.74
194 0.71 0.67 0.48 0.42 0.81 0.80 0.11 0.70 0.72 0.54 0.91 0.53
28 0.29 0.32 0.40 0.23 0.29 0.26 0.18 0.23 0.27 0.44 0.20 0.41
66 0.46 0.48 0.61 0.25 0.44 0.43 0.11 0.39 0.44 0.62 0.43 0.69
60 0.12 0.14 0.19 0.26 0.09 0.09 0.16 0.08 0.08 0.13 0.06 0.15
157 0.84 0.85 0.70 0.44 0.85 0.76 0.09 0.68 0.92 0.75 0.79 0.72
44 0.11 0.11 0.13 0.16 0.10 0.15 0.48 0.11 0.08 0.07 0.05 0.07
193 0.32 0.32 0.21 0.20 0.39 0.42 0.00 0.15 0.35 0.25 0.40 0.25
90/101 0.21 0.22 0.33 0.31 0.24 0.28 0.14 0.23 0.21 0.23 0.30 0.39
128 0.31 0.31 0.36 0.46 0.34 0.35 0.00 0.28 0.30 0.32 0.36 0.41
Entries are Pearson correlations on the logarithmic scale.
Table 3. Correlations among PCB congeners in 497 milk samples from Canada in 1992, for those with
40–90% quantiﬁed.
Congener 99 199 183 194 28 66 60 157 44 193 90/101 128
99 1
199 0.40 1
183 0.66 0.83 1
194 0.39 0.89 0.78 1
28 0.28 0.20 0.27 0.17 1
66 0.49 0.39 0.51 0.35 0.57 1
60 0.15 0.05 0.19 0.06 0.25 0.26 1
157 0.58 0.74 0.84 0.72 0.26 0.49 0.07 1
44 0.00 0.08 0.08 0.08 0.14 0.09 0.27 0.03 1
193 0.22 0.43 0.43 0.47 0.12 0.19 0.00 0.47 0.05 1
90/101 0.26 0.30 0.35 0.24 0.33 0.67 0.43 0.32 0.27 0.11 1
128 0.30 0.35 0.38 0.29 0.23 0.38 0.19 0.38 0.00 0.11 0.31 1
Entries are Pearson correlations on the logarithmic scale.
Table 4. Distribution of other major organochlorine compounds in 497 milk samples from Canada in 1992.
Percent Median 90th percentile Maximum
Compound quantiﬁed (ng/g lipid) (ng/g lipid) (ng/g lipid)
p,p’-DDE 100.0 168.6 401.9 3,783
trans-Nonachlor 100.0 15.8 27.4 85
Hexachlorobenzene 100.0 13.0 20.3 323
p,p’-DDT 99.2 18.7 32.5 287
Oxychlordane 97.4 12.5 21.2 81
Dieldrin 94.4 8.5 16.9 103
β-Hexachlorocyclohexane 93.4 18.7 37.5 307
o,p’-DDT 82.1 2.8 5.0 39
Pentachlorobenzene 72.0 1.3 2.7 26
cis-Nonachlor 70.0 2.2 7.1 62
Heptachlor epoxide 68.4 2.6 8.4 67
Mirex 57.5 1.7 4.6 30
1,2,3-Trichlorobenzene 54.1 1.9 5.9 236
1,2,4-Trichlorobenzene 49.1 3.4 9.2 118reports giving correlations. Larsen et al.
(1994) measured six congeners; virtually all of
the variance was explained by a single princi-
pal component, indicating a high degree of
intercorrelation. Angulo et al. (1999) sug-
gested a main group of six congeners, with
three other groups involving five congeners.
Moysich et al. (1999) suggested that 33 con-
geners should be split into ﬁve groups. Löfﬂer
and van Bavel (2000) suggested that four con-
geners be split into two groups.
We found congeners 138, 153, 156, 157,
170, 183, 187, 194, 199, and 203 to be
highly intercorrelated, with congener 180
having somewhat lower but still high correla-
tions with this group. This generally agrees
with what has been seen in the literature cited
above. Congener 180 was sometimes more
highly correlated in previous literature than
we found it to be; congeners 156 and 170
sometimes had less correlation than we saw.
Correlations for congeners 194, 199, and 203
have not been studied previously to our
knowledge. We found congeners 74, 105,
and 118 to be highly intercorrelated and
moderately to highly correlated with the ﬁrst
group. Again, this is in good agreement with
the previous literature. We found congener
99 to have moderate correlations with both
these groups; previous results show moderate
to high correlations. We found congener 66
to have lesser correlations with the primary
group; two previous studies of this congener
have been inconsistent.
In addition to the congeners we studied,
others have been found to be part of this
highly intercorrelated group. Congeners 126
(chlorine structure 345-34) and 169 (struc-
ture 345-345), both present at much lower
concentrations than those we studied, have
repeatedly been shown to have moderate to
high correlations with the main group
(Dewailly et al. 1991; Gladen et al. 1999a;
Glynn et al. 2001; Longnecker et al. 2000;
van den Berg et al. 1995), as has 167 (struc-
ture 245-345) (Glynn et al. 2000, 2001; van
den Berg et al. 1995). Furthermore, metabo-
lites of major PCBs have usually been shown
to be highly correlated with the parent com-
pounds, as well as with other PCBs correlated
with the parents (Newsome and Davies 1996;
Sandau et al. 2002; Sjödin et al. 2000).
In contrast to the coherent picture pre-
sented by these congeners, congeners 28, 44,
49, 60, 90/101, 128, 137, and 193 showed
little correlation with each other or with other
congeners in our study. Most previous studies
of congener 28 and 90/101 cited above show
the same pattern of lack of correlation with
other congeners. Correlations for congener 49
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Table 5. Correlations among other major organochlorine compounds in 497 milk samples from Canada in 1992.
Compound p,p’-DDE trans-non HCB p,p’-DDT Oxychlor Dieldrin β-HCH o,p’-DDT PnCB cis-non Hep epox Mirex 1,2,3-TCB 1,2,4-TCB
p,p’-DDE 1
trans-non 0.68 1
HCB 0.58 0.72 1
p,p’-DDT 0.56 0.46 0.54 1
Oxychlor 0.50 0.76 0.73 0.57 1
Dieldrin 0.32 0.37 0.28 0.30 0.30 1
β-HCH 0.48 0.46 0.57 0.50 0.59 0.28 1
o,p’-DDT 0.57 0.58 0.46 0.50 0.39 0.31 0.28 1
PnCB 0.19 0.25 0.27 0.19 0.14 0.13 0.07 0.27 1
cis-non 0.45 0.67 0.49 0.37 0.59 0.40 0.42 0.43 0.21 1
Hep epox 0.33 0.36 0.31 0.25 0.31 0.65 0.42 0.22 0.27 0.42 1
Mirex 0.23 0.37 0.26 0.26 0.23 0.16 0.13 0.31 0.27 0.26 0.18 1
1,2,3-TCB 0.24 0.29 0.29 0.25 0.18 0.18 0.07 0.25 0.40 0.30 0.19 0.29 1
1,2,4-TCB 0.26 0.35 0.28 0.21 0.27 0.19 0.06 0.28 0.43 0.35 0.26 0.34 0.77 1
Abbreviations: cis-non, cis-nonachlor; HCB, hexachlorobenzene; β-HCH, β-hexachlorocyclohexane; hep epox, heptachlor epoxide; oxychlor, oxychlordane; PnCB, pentachlorobenzene;
1,2,3-TCB, 1,2,3-trichlorobenzene; 1,2,4-TCB, 1,2,4-trichlorobenzene; trans-non, trans-nonachlor. Entries are Pearson correlations on the logarithmic scale.
Table 6. Correlations of PCB congeners with other major organochlorine compounds in 497 milk samples from Canada in 1992.
Congener(s) p,p’-DDE trans-non HCB p,p’-DDT Oxychlor Dieldrin β-HCH o,p’-DDT PnCB cis-non Hep epox Mirex 1,2,3-TCB 1,2,4-TCB
153 0.73 0.80 0.64 0.46 0.55 0.31 0.37 0.70 0.25 0.48 0.27 0.38 0.30 0.35
138 0.73 0.79 0.65 0.48 0.56 0.33 0.37 0.73 0.24 0.45 0.27 0.37 0.29 0.33
118 0.65 0.68 0.58 0.49 0.49 0.28 0.35 0.71 0.18 0.42 0.26 0.33 0.28 0.28
137 0.30 0.28 0.24 0.46 0.14 0.21 0.18 0.24 0.14 0.00 0.13 0.46 0.16 0.08
170 0.63 0.74 0.60 0.41 0.51 0.33 0.35 0.62 0.29 0.45 0.28 0.48 0.31 0.34
187 0.64 0.71 0.55 0.47 0.48 0.30 0.38 0.60 0.23 0.49 0.26 0.42 0.27 0.27
49 0.19 0.26 0.30 0.31 0.13 0.04 0.24 0.20 0.21 0.07 0.20 0.08 0.22 0.11
180 0.56 0.65 0.53 0.39 0.42 0.28 0.33 0.50 0.21 0.36 0.26 0.33 0.35 0.30
156 0.62 0.75 0.59 0.42 0.54 0.29 0.33 0.67 0.24 0.42 0.27 0.42 0.29 0.34
74 0.68 0.77 0.67 0.47 0.61 0.32 0.39 0.68 0.20 0.48 0.28 0.33 0.26 0.34
203 0.55 0.63 0.45 0.39 0.40 0.31 0.29 0.57 0.27 0.45 0.25 0.46 0.29 0.31
105 0.58 0.63 0.55 0.44 0.48 0.29 0.36 0.73 0.23 0.47 0.28 0.38 0.26 0.30
99 0.59 0.55 0.44 0.44 0.49 0.32 0.29 0.56 0.20 0.33 0.22 0.22 0.18 0.26
199 0.49 0.57 0.42 0.38 0.37 0.26 0.30 0.51 0.24 0.40 0.20 0.42 0.23 0.22
183 0.68 0.71 0.58 0.52 0.50 0.35 0.37 0.68 0.31 0.51 0.28 0.46 0.33 0.33
194 0.46 0.54 0.40 0.35 0.32 0.25 0.22 0.50 0.25 0.38 0.18 0.45 0.23 0.24
28 0.27 0.26 0.36 0.34 0.27 0.22 0.25 0.34 0.22 0.12 0.17 0.18 0.11 0.09
66 0.36 0.42 0.37 0.37 0.33 0.29 0.27 0.53 0.40 0.38 0.32 0.35 0.33 0.31
60 0.13 0.06 0.07 0.24 0.03 0.14 0.17 0.17 0.09 0.00 0.20 0.07 –0.16 0.00
157 0.54 0.62 0.53 0.46 0.49 0.24 0.26 0.64 0.24 0.43 0.22 0.48 0.28 0.35
44 0.06 0.18 0.15 0.17 0.05 0.00 0.10 0.15 0.25 0.07 0.21 0.13 0.14 0.13
193 0.23 0.20 0.18 0.29 0.13 0.02 0.02 0.29 0.14 0.21 0.02 0.22 0.18 0.16
90/101 0.16 0.18 0.18 0.26 0.12 0.26 0.24 0.34 0.33 0.24 0.35 0.28 0.17 0.18
128 0.23 0.25 0.26 0.32 0.28 0.16 0.34 0.29 0.07 0.20 0.15 0.32 0.01 0.03
Abbreviations: cis-non, cis-nonachlor; HCB, hexachlorobenzene; β-HCH, β-hexachlorocyclohexane; hep epox, heptachlor epoxide; oxychlor, oxychlordane; PnCB, pentachlorobenzene;
1,2,3-TCB, 1,2,3-trichlorobenzene; 1,2,4-TCB, 1,2,4-trichlorobenzene; trans-non, trans-nonachlor. Entries are Pearson correlations on the logarithmic scale.were studied once previously; in that study, it
was rarely detected, but the detection limit
was quite high, so little real information was
available (Moysich et al. 1999). The remain-
ing congeners in this list are unstudied or
were rarely found.
It would be useful if correlation patterns
were related to structure in some predictable
way. There is some tendency for more highly
chlorinated congeners to be part of intercorre-
lated groups. For example, the group of 10
highly intercorrelated congeners we observed
includes four hexachlorinated, three hep-
tachlorinated, and three octachlorinated con-
geners. However, it is unwise to rely on this
pattern; the eight congeners we identify as
having essentially no correlation with others
include one trichlorinated, three tetrachlori-
nated, one pentachlorinated, two hexachlori-
nated, and one heptachlorinated congener.
The position of the chlorines present might
also be thought to be a useful predictor. We
observed a grouping of three congeners with
chlorines in ortho positions on only one ring.
However, the behavior of the mono-orthos is
not consistent; of the six other mono-ortho
congeners examined, two are part of the main
highly correlated group, one has modest cor-
relations with the main group or the mono-
ortho cluster, and three have little correlation
with any other congeners.
The results demonstrated here have impli-
cations for epidemiologic studies relating
PCB concentrations to health outcomes in
the general population. In older epidemio-
logic studies, the practical available technolo-
gies produced only measures of total PCBs.
The increasing development of realistic meth-
ods to measure many individual congeners
has opened the door to other possibilities,
although relatively few studies have made use
of this information. In thinking about appro-
priate ways to proceed, one may consider
congeners as roughly being of three kinds, for
which different considerations apply.
One group is a set of highly intercorrelated
congeners, including most of the major con-
geners. The high degree of correlation consis-
tently seen among this group means that their
biologic effects cannot realistically be separated
in human studies. Studying the relationship of
each of these congeners to the health outcome
in question might possibly suggest associations,
especially if there is supporting evidence from
laboratory experiments to guide interpretation.
However, it would be, at best, difﬁcult for epi-
demiologic studies to distinguish congeners or
metabolites truly related to the outcome from
those that are simply fellow travelers through
the environment. The difﬁculty is inherent in
the available data and represents intractable
confounding that cannot be overcome by use
of alternate statistical analysis methods.
Measurement of multiple congeners from this
group would add little information regarding
their separate health effects; this has led to the
suggestion of using a single congener, usually
153, to represent the whole group when study-
ing associations with health outcomes
(Brouwer et al. 1995).
Another group of congeners will be
deﬁned partly by the assay methods used in or
proposed for a study. It consists of those that
are quantiﬁable in only a small fraction of the
population when using those methods.
Measurement of such congeners will generally
be uninformative for epidemiologic studies.
Some of these congeners could certainly be of
Articles | Lessons from patterns of PCBs in humans
Environmental Health Perspectives • VOLUME 111 | NUMBER 4 | April 2003 441
Table 7. Other studies examining correlation patterns among PCB congeners.
Study Samples Results presented
Holford et al. Breast adipose tissue from 490 women, case–control study  Pearson correlations (eliminating one outlier) among congeners 74, 118, 
(2000) of breast cancer, 40–79 years old, United States, 1994–1997 138, 153, 156, 170, 180, 183, 187
Koopman-Esseboom  Milk, plasma, cord plasma from 418 new mothers,  Spearman correlations among congeners 118, 138, 153, 180
et al. (1994) mean age 29 years old, Netherlands,1990–1992
Gladen et al.  Milk from 197 new mothers, 16–45 years old,  Spearman correlations among congeners 8/5, 18/17, 28, 44, 52, 66, 101/90, 
(1999b) Ukraine, 1993–1994  105, 118, 128, 138/160, 153/132, 170/190, 180, 187, 195/208, 206, 209
Daniel et al.  Blood from 141 male and female patients with varying  Spearman correlations among congeners 101, 138, 153, 180
(2001) complaints, 8–74 years old, Germany, 1992–1998
Glynn et al.  Serum from 120 men, 40–74 years old, Sweden Spearman correlations among congeners 28, 52, 101, 105, 118, 138, 153, 
(2000) 156, 167, 180
DeVoto et al.  Serum from 98 male and female ﬁshing boat captains, Pearson correlations (logarithmic scale) among congeners 138, 153, 180
(1997) 20–71 years old, United States, 1991
DeVoto et al.  Plasma from 66 women, controls from breast cancer study,  Pearson correlations (logarithmic scale) among congeners 74, 99, 118, 138, 
(1997) 28–74 years old, United States, 1993–1995 153, 180
Longnecker et al.  Plasma from 63 male and female blood donors,  Pearson correlations (logarithmic scale) among congeners 99, 118, 126,
(2000) 17–67 years old, Canada, 1994 138, 153, 156, 169, 170, 180, 187
Luotamo et al.  Adipose tissue from 59 autopsies, 15–83 years old, Finland Pearson correlations among congeners 18, 28, 33, 47, 66, 74, 101, 138, 153, 
(1991) (28 serum samples from those 57–83 years old) 156, 171, 183
DeVoto et al.  Serum from 56 male and female anglers,  Pearson correlations (logarithmic scale) among congeners 138, 153, 180
(1997) 29–77 years old, United States, 1991
Gladen et al.  Blood from 44 male veterans, 41–66 years old,  Spearman correlations among congeners 28, 74, 77, 99, 105, 118, 126, 138, 
(1999a) United States, 1991–1992 153, 156, 169, 170, 180, 187
Van den Berg  Milk from 32 new mothers, Netherlands Correlations of congeners 118, 153 with 105, 126, 156, 157, 167, 169
et al. (1995)
Glynn et al.  Milk from 27 new mothers, 22–35 years old,  Spearman correlations among congeners 28, 105, 118, 126, 138, 153, 156, 
(2001) Sweden, 1996–1999 167, 169, 180
Bush et al.  Milk from 20 new mothers, United States, 1979 Pearson correlations of congeners 1, 8, 28 with 23 congeners, and of 
(1985) congeners 82, 180 with 32 congeners
Bush et al.  Milk from 13 new mothers, United States, 1979 Pearson correlations of congeners 1, 8, 28 with 23 congeners, and of 
(1985) congeners 82, 180 with 32 congeners
Larsen et al.  Milk from 64 new mothers, Italy, some samples pooled  Interpretation of principal components of congeners 28, 74, 118, 153, 
(1994) prior to analysis 180, 194
Angulo et al.  Milk from 100 new mothers, 15–47 years old,  Interpretation of principal components as four groups: (congeners 138, 153, 
(1999) Spain, 1993–1994 180, 183, 170, 187), (28, 52), (101, 188), (118)
Moysich et al.  Serum from 192 postmenopausal women,  Interpretation of factor analysis as ﬁve groups: (congeners 156/171, 172, 
(1999) 45–81 years old, United States, 1986–1991 180, 187, 194, 195, 203/196, 206), (105/132, 118, 138, 147, 153, 188), (6, 
7/9, 47/48, 87, 134, 177), (22, 31/28, 66/95, 101, 128, 129, 141/179, 
174/181), (77/110,176, 183, 201 [called 200 in original], 205)
Löfﬂer and van Bavel Blood from 309 male and female patients with  Interpretation of principal components as two groups: (138, 153, 180), (101)
(2000) unspeciﬁed symptoms, Germany, 1992–1995 biologic interest, depending on the health
outcome under study (Hansen 1998; Rose et
al. 2002). However theoretically interesting
these congeners may be, studies of their bio-
logic effects will normally yield little if they
are present at concentrations too low for the
assay methods to reliably distinguish samples
with large and small concentrations, or if only
a few individuals can be clearly distinguished
from those whose concentrations are unquan-
tifiable. Results involving such congeners
should be scrutinized carefully; samples that
have quantifiable amounts may differ from
those not quantiﬁable simply by having larger
sample volume or greater lipid content. If the
aim of a particular epidemiologic study
requires measurement of such congeners,
alternate assay methods may be needed.
Finally, there are congeners that fall into
neither of these groups. They are quantiﬁable
in a reasonable fraction of samples and they
do not correlate highly with the bulk of major
congeners. Measurement of such congeners is
neither redundant nor uninformative and will
add to the picture of contamination. These
congeners are prime candidates for inclusion
in epidemiologic studies.
Of course, which congeners should be
measured in any speciﬁc epidemiologic study
will depend on the purpose of the study. If
the question being investigated involves a spe-
cific congener or set of congeners, then the
decision is simple. If the question is broader
based, the decision becomes correspondingly
less clear. Decisions about which congeners to
measure will then depend partly on the con-
centrations and patterns seen in the particular
population under study. This may well
require pilot studies. Some patterns appear to
be nearly universal; for example, all the evi-
dence to date suggests that congeners 138 and
153 may safely be assumed to be major con-
geners, highly correlated with each other, in
all populations. Other patterns vary consider-
ably; for example, congeners such as 49 and
137, both major congeners in this population,
were present in much lower concentrations in
other populations (DeCaprio et al. 2000;
Humphrey et al. 2000).
We also examined the relationships
between PCBs and other organochlorine
compounds. The source of these other
organochlorines would, of course, be different
from PCBs. However, they tend to travel the
same pathways as PCBs once they enter the
environment, so similar concerns about
whether health effects can be distinguished
arise. There have been previous examinations
of relationships of PCBs and other
organochlorines, with quite disparate results.
For example, in a study of 858 American
infants born in 1978–1982, the correlation of
PCBs and p,p´-DDE was only 0.23 (Rogan et
al. 1987). In samples taken in 1993–1995
from a group of 180 U.S. residents, about
half of whom ate presumably contaminated
fish, PCBs and p,p´-DDE had a Spearman
correlation of 0.64 (Schantz et al. 1999). In a
recent study of 120 Swedish men, correlations
between p,p´-DDE and seven major PCBs
ranged from 0.37 to 0.76 (Glynn et al. 2000).
Generalizations do not seem feasible here, and
the correlations seen in each individual popu-
lation would need to be examined.
In summary, PCB patterns seen in
humans are complex, partly predictable, and
partly unpredictable. Studies of the relation-
ship of PCBs to health outcomes need to be
designed, where feasible, to accommodate
these patterns. The congeners examined in
most epidemiologic studies to date provide
little more information than would measure-
ment of a single representative congener.
Consideration should be given to measure-
ment of other congeners less correlated with
these, as long as assay methods adequate to
allow quantitation are used.
REFERENCES
Angulo R, Martínez P, Jodral ML. 1999. PCB congeners trans-
ferred by human milk, with an estimate of their daily
intake. Food Chem Toxicol 37:1081–1088.
ATSDR. 2000. Toxicological Proﬁle for Polychlorinated Biphenyls
(PCBs). Atlanta, GA:Agency for Toxic Substances and
Disease Registry.
Brouwer A, Ahlborg UG, Van den Berg M, Birnbaum LS,
Boersma ER, Bosveld B, et al. 1995. Functional aspects of
developmental toxicity of polyhalogenated aromatic
hydrocarbons in experimental animals and human infants.
Eur J Pharmacol 293:1–40.
Burgin DE, Diliberto JJ, Derr-Yellin EC, Kannan N, Kodavanti
PRS, Birnbaum LS. 2001. Differential effects of two lots of
Aroclor 1254 on enzyme induction, thyroid hormones, and
oxidative stress. Environ Health Perspect 109:1163–1168.
Bush B, Snow J, Connor S, Koblintz R. 1985. Polychlorinated
biphenyl congeners (PCBs), p,p´-DDE and hexachloroben-
zene in human milk in three areas of upstate New York.
Arch Environ Contam Toxicol 14:443–450.
Daniel V, Huber W, Bauer K, Suesal C, Conradt C, Opelz G. 2001.
Associations of blood levels of PCB, HCHs, and HCB with
numbers of lymphocyte subpopulations, in vitro lymphocyte
response, plasma cytokine levels, and immunoglobulin
autoantibodies. Environ Health Perspect 109:173–178.
DeCaprio AP, Tarbell AM, Bott A, Wagemaker DL, Williams RL,
O’Hehir CM. 2000. Routine analysis of 101 polychlorinated
biphenyl congeners in human serum by parallel dual-col-
umn gas chromatography with electron capture detection.
J Anal Toxicol 24:403–420.
DeVoto E, Fiore BJ, Millikan R, Anderson HA, Sheldon L,
Sonzogni WC, et al. 1997. Correlations among human blood
levels of speciﬁc PCB congeners and implications for epi-
demiologic studies. Am J Ind Med 32:606–613.
Dewailly É, Weber JP, Gingras S, Laliberté C. 1991. Coplanar
PCBs in human milk in the province of Québec, Canada:
are they more toxic than dioxin for breast fed infants? Bull
Environ Contam Toxicol 47:491–498.
Erickson MD. 1997. Analytical Chemistry of PCBs. 2nd ed. Boca
Raton, FL:CRC Lewis Publishers.
Frame GM. 2001. The current state-of-the-art of comprehen-
sive, quantitative, congener-specific PCB analysis, and
what we now know about the distributions of individual
congeners in commercial Aroclor mixtures. In: PCBs:
Recent Advances in Environmental Toxicology and Health
Effects (Robertson LW, Hansen LG, eds). Lexington,
KY:University Press of Kentucky, 3–9.
Gladen BC, Longnecker MP, Schecter AJ. 1999a. Correlations
among polychlorinated biphenyls, dioxins, and furans in
humans. Am J Ind Med 35:15–20.
Gladen BC, Monaghan SC, Lukyanova EM, Hulchiy OP,
Shkyryak-Nyzhnyk ZA, Sericano JL, et al. 1999b.
Organochlorines in breast milk from two cities in Ukraine.
Environ Health Perspect 107:459–462.
Glynn AW, Atuma S, Aune M, Darnerud PO, Cnattingius S. 2001.
Polychlorinated biphenyl congeners as markers of toxic
equivalents of polychlorinated biphenyls, dibenzo-p-diox-
ins and dibenzofurans in breast milk. Environ Res
86:217–228.
Glynn AW, Wolk A, Aune M, Atuma S, Zettermark S, Mæhle-
Schmid M, et al. 2000. Serum concentrations of
organochlorines in men: a search for markers of exposure.
Sci Total Environ 263:197–208.
Hansen LG. 1998. Stepping backward to improve assessment of
PCB congener toxicities. Environ Health Perspect
106(suppl 1):171–189.
Holford TR, Zheng T, Mayne ST, Zahm SH, Tessari JD, Boyle P.
2000. Joint effects of nine polychlorinated biphenyl (PCB)
congeners on breast cancer risk. Int J Epidemiol 29:975–982.
Hsu CC, Yu MLM, Chen YCJ, Guo YLL, Rogan WJ. 1994. The Yu-
cheng rice oil poisoning incident. In: Dioxins and Health
(Schecter A, ed). New York:Plenum Press, 661–684.
Humphrey HEB, Gardiner JC, Pandya JR, Sweeney AM, Gasior
DM, McCaffrey RJ, et al. 2000. PCB congener proﬁle in the
serum of humans consuming Great Lakes fish. Environ
Health Perspect 108:167–172.
Jensen RG, Ferris AM, Lammi-Keefe CJ. 1992. Lipids in human
milk and infant formulas. Annu Rev Nutr 12:417–441.
Jones KC. 1988. Determination of polychlorinated biphenyls in
human foodstuffs and tissues: suggestions for a selective
congener analytical approach. Sci Total Environ 68:141–159.
Kaplan EL, Meier P. 1958. Nonparametric estimation from
incomplete observations. J Am Stat Assoc 53:457–481.
Kodavanti PRS, Kannan N, Yamashita N, Derr-Yellin EC, Ward
TR, Burgin DE, et al. 2001. Differential effects of two lots of
Aroclor 1254: congener-speciﬁc analysis and neurochemi-
cal end points. Environ Health Perspect 109:1153–1161.
Koopman-Esseboom C, Huisman M, Weisglas-Kuperus N, Van
der Paauw CG, Tuinstra LGMT, Boersma ER, et al. 1994.
PCB and dioxin levels in plasma and human milk of 418
Dutch women and their infants: predictive value of PCB
congener levels in maternal plasma for fetal and infant’s
exposure to PCBs and dioxins. Chemosphere 28:1721–1732.
Larsen BR, Turrio-Baldassarri L, Nilsson T, Iacovella N, di
Domenico A, Montagna M, et al. 1994. Toxic PCB con-
geners and organochlorine pesticides in Italian human
milk. Ecotoxicol Environ Saf 28:1–13.
Li MH, Hansen LG. 1996a. Enzyme induction and acute
endocrine effects in prepubertal female rats receiving
environmental PCB/PCDF/PCDD mixtures. Environ Health
Perspect 104:712–722.
———. 1996b. Responses of prepubertal female rats to envi-
ronmental PCBs with high and low dioxin equivalencies.
Fundam Appl Toxicol 33:282–293.
Löfﬂer G, van Bavel B. 2000. Potential pathways and exposure
to explain the human body burden of organochlorine com-
pounds: a multivariate statistical analysis of human moni-
toring in Würzburg, Germany. Chemosphere 40:1075–1082.
Longnecker MP, Rogan WJ, Lucier G. 1997. The human health
effects of DDT (dichlorodiphenyltrichloroethane) and
PCBs (polychlorinated biphenyls) and an overview of
organochlorines in public health. Annu Rev Public Health
18:211–244.
Longnecker MP, Ryan JJ, Gladen BC, Schecter AJ. 2000.
Correlations among human plasma levels of dioxin-like
compounds and polychlorinated biphenyls (PCBs) and
implications for epidemiologic studies. Arch Environ
Health 55:195–200.
Luotamo M, Järvisalo J, Aitio A. 1991. Assessment of exposure
to polychlorinated biphenyls: analysis of selected isomers
in blood and adipose tissue. Environ Res 54:121–134.
Masuda Y. 1994. The Yusho rice oil poisoning incident. In:
Dioxins and Health (Schecter A, ed). New York:Plenum
Press, 633–659.
McFarland VA, Clarke JU. 1989. Environmental occurrence,
abundance, and potential toxicity of polychlorinated
biphenyl congeners: considerations for a congener-spe-
ciﬁc analysis. Environ Health Perspect 81:225–239.
Moysich KB, Mendola P, Schisterman EF, Freudenheim JL,
Ambrosone CB, Vena JE, et al. 1999. An evaluation of pro-
posed frameworks for grouping polychlorinated biphenyl
(PCB) congener data into meaningful analytic units. Am J
Ind Med 35:223–231.
Newsome WH, Davies D. 1996. Determination of PCB metabo-
lites in Canadian human milk. Chemosphere 33:559–565.
Articles | Gladen et al.
442 VOLUME 111 | NUMBER 4 | April 2003 • Environmental Health PerspectivesNewsome WH, Davies D, Doucet J. 1995. PCB and organochlo-
rine pesticides in Canadian human milk—1992.
Chemosphere 30:2143–2153.
Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P,
Thullen J, et al. 1987. Polychlorinated biphenyls (PCBs)
and dichlorodiphenyl dichloroethene (DDE) in human milk:
effects on growth, morbidity, and duration of lactation. Am
J Public Health 77:1294–1297.
Rose RL, Khan MA, Li MH, Gillette JS, Hansen LG. 2002.
Endocrine effects of episodic polychlorinated biphenyl
(PCB) congeners. Rev Toxicol 2:1–18.
Sandau CD, Ayotte P, Dewailly É, Duffe J, Norstrom RJ. 2002.
Pentachlorophenol and hydroxylated polychlorinated
biphenyl metabolites in umbilical cord plasma of neonates
from coastal populations in Québec. Environ Health
Perspect 110:411–417.
Schantz SL, Gardiner JC, Gasior DM, Sweeney AM, Humphrey
HEB, McCaffrey RJ. 1999. Motor function in aging Great
Lakes ﬁsheaters. Environ Res 80:S46–S56.
Schecter A, Stanley J, Boggess K, Masuda Y, Mes J, Wolff M,
et al. 1994. Polychlorinated biphenyl levels in the tissues of
exposed and nonexposed humans. Environ Health
Perspect 102(suppl 1):149–158.
Sjödin A, Hagmar L, Klasson-Wehler E, Björk J, Bergman Å.
2000. Inﬂuence of the consumption of fatty Baltic Sea ﬁsh
on plasma levels of halogenated environmental contami-
nants in Latvian and Swedish men. Environ Health
Perspect 108:1035–1041.
Van den Berg M, Birnbaum L, Bosveld ATC, Brunström B, Cook
P, Feeley M, et al. 1998. Toxic equivalency factors (TEFs)
for PCBs, PCDDs, PCDFs for humans and wildlife. Environ
Health Perspect 106:775–792.
Van den Berg M, Sinnige TL, Tysklind M, Bosveld ATC,
Huisman M, Koopmans-Essenboom C, et al. 1995.
Individual PCBs as predictors for concentrations of non
and mono-ortho PCBs in human milk. Environ Sci Pollut
Res Int 2:73–82.
Wolff MS, Camann D, Gammon M, Stellman SD. 1997. Proposed
PCB congener groupings for epidemiological studies.
Environ Health Perspect 105:13–14.
Articles | Lessons from patterns of PCBs in humans
Environmental Health Perspectives • VOLUME 111 | NUMBER 4 | April 2003 443